U.S. Healthtech Stock News

Why Schneider National Stock Is Getting Attention Now With no single headline event setting the tone, Schneider National (SNDR) is drawing interest as investors weigh its recent share performance, profitability metrics, and scale across truckload, intermodal, and logistics operations. See our latest analysis for Schneider National. Schneider National’s recent share price has been relatively firm at US$28.16, with a 20.14% 90 day share price return and a 9.73% 1 year total shareholder return...

Datadog (NasdaqGS:DDOG) has entered a new partnership with Sakana AI focused on enterprise AI adoption and joint research. The collaboration targets large enterprises in Japan first, with an intention to extend offerings to global customers over time. Both companies plan to combine Datadog's cloud and monitoring capabilities with Sakana AI's scalable models for real world deployments. Datadog, trading at around $111.11, sits in an interesting spot for investors reviewing its recent...

Nexa Resources S.A. reported a turnaround in its 2025 results, with sales of US$3,002.06 million, net income of US$132.63 million, a US$12.5 million impairment on long-lived assets, and a proposed dividend of about US$17.5 million (US$0.132136 per share) for payment in August 2026, subject to AGM approval. The company’s return to profitability alongside a proposed cash dividend, while reaffirming 2026 production guidance after only minimal disruption at the Atacocha mine, highlights...

Centuri Holdings (CTRI) has turned heads after reporting record 2025 revenue, a sharply higher year end backlog of about $5.9b, and issuing 2026 guidance that points to higher revenue and profit targets. See our latest analysis for Centuri Holdings. That record 2025 result and larger backlog have come after a strong run in the share price, with a 30 day share price return of 12.10% and a 90 day return of 26.49%. The 1 year total shareholder return of 92.17% suggests momentum has been...

Cogent Communications Holdings recently reported fourth-quarter 2025 and full-year results showing a reduced net loss of US$30.78 million for the quarter and US$182.17 million for the year, and on February 18, 2026 its board approved a regular first-quarter 2026 dividend of US$0.02 per share payable March 20, 2026. The combination of narrowing losses and maintaining a cash dividend highlights management’s continued focus on shareholder distributions even while the business remains...

Limbach Holdings (LMB) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales, net income and earnings per share compared with the prior year periods. See our latest analysis for Limbach Holdings. The latest earnings release comes after a strong run in the shares, with a 90 day share price return of 29.7% and a 1 year total shareholder return of 15.65%. The 3 year total shareholder return is around 7x, and recent weekly moves have cooled short term...

For investors wondering if Century Communities at around US$65.99 offers solid value, this article walks through what the numbers indicate about the stock today. The share price has seen mixed recent returns, with about a 5.7% decline over the last 7 days, a 4.8% gain over 30 days, around 12.0% year to date, and roughly a 1.0% decline over the past year. This combination can leave investors unsure how to interpret the risk and reward trade off. Recent coverage of homebuilders and housing...

If you are wondering whether Abbott Laboratories at about US$114 per share is offering fair value right now, you are not alone. This article walks through how that price stacks up against a few different valuation yardsticks. The stock has seen mixed returns, with a 1% decline over the past week, a 4.4% gain over the last 30 days, and longer term moves of an 8.1% gain over 5 years but a 17.1% decline over the past year and an 8.1% decline year to date, which may signal shifting expectations...

Cytokinetics (NasdaqGS:CYTK) has secured regulatory approval from both the FDA and the European Commission for MYQORZO™, a treatment for obstructive hypertrophic cardiomyopathy (oHCM). MYQORZO™ is expected to reach patients in the U.S. and Europe with sales commencing in Q1 2026. The approvals open access to two major markets and introduce a new potential revenue source for Cytokinetics. Cytokinetics enters this phase with MYQORZO™ approved on both sides of the Atlantic and a current share...

If you are wondering whether American Financial Group at around US$134.50 is offering fair value or hiding a margin of safety, you are not alone. The stock closed at US$134.50 with returns of 3.8% over the past week, 3.2% over the past month, a slight year to date decline of 0.2%, and an 11.9% return over the past year, with 21.6% over three years and 96.8% over five years. Recent attention on American Financial Group has focused on its position as a specialist insurer and how investors are...

Domino's Pizza (DPZ) is back in focus after reporting detailed fourth quarter and full year 2025 results, pairing those figures with a double digit dividend increase and updates on store growth and share repurchases. See our latest analysis for Domino's Pizza. The recent earnings release, dividend increase and update on buybacks come against a softer share price backdrop, with a 90 day share price return of a 5.48% decline and a 1 year total shareholder return of a 15.72% decline, hinting...

Recent performance snapshot THOR Industries (THO) has drawn investor attention after a stretch of weaker returns, with the stock down about 11% over the past week and about 14% over the past month. That share performance sits against annual revenue of roughly US$9.83b and net income of about US$282 million. This gives investors a current reference point as they think about the recreational vehicle maker’s valuation and prospects. See our latest analysis for THOR Industries. At around US$95.69...

Kimbell Royalty Partners, LP reported past fourth-quarter 2025 results showing revenue of US$82.45 million and net income of US$21.83 million, alongside full-year 2025 revenue of US$333.83 million and net income of US$90.95 million, and declared a Q4 2025 cash distribution of US$0.37 per common unit. The partnership also issued 2026 production guidance of 24.0–27.0 Mboe/d with a balanced mix of oil, natural gas, and NGLs, while highlighting a US$230 million Midland Basin acquisition and the...

In February 2026, Redwire Corporation refinanced its debt with a new US$30 million revolving credit facility and a US$90 million term loan maturing in 2029, while reporting fourth-quarter 2025 sales of US$108.79 million and a quarterly net loss of US$85.47 million. The company paired this refinancing with 2026 revenue guidance of US$450 million to US$500 million, signaling an effort to align its balance sheet with ambitions for faster top-line expansion despite ongoing losses. Now we’ll...

Recent share performance and business snapshot Crown Holdings (CCK) has attracted attention after a strong run, with the stock showing positive returns over the past month and past 3 months. This has prompted investors to reassess the packaging group’s profile. The company reports annual revenue of US$12.365b and net income of US$738.0m. Its business is spread across Americas Beverage, European Beverage, Asia Pacific, and Transit Packaging segments in recyclable cans, bottles, closures, and...

If you are wondering whether Carnival Corporation & at around US$29.14 is still offering value after its rebound in recent years, you are not alone. The stock has seen mixed recent returns, with a 4.2% decline over the last 7 days and a 2.9% decline over the last 30 days, while still sitting on a 25.9% gain over 1 year and a very large 3 year return that is around 2.5x, alongside a 9.7% return over 5 years. These moves have come as investors react to ongoing headlines around cruise demand,...

In February 2026, Reliance, Inc. reported higher fourth-quarter and full-year 2025 sales and earnings than a year earlier, raised its quarterly dividend to US$1.25 per share, updated first-quarter 2026 volume guidance, and disclosed further progress on a long-running share repurchase program totaling about US$4.70 billion to date. The mix of earnings growth, a dividend increase, and continued buybacks highlights Reliance’s focus on returning cash to shareholders while managing volume and...

American Airlines Group (AAL) has come into focus after filing an omnibus shelf registration for common shares and debt securities, alongside reporting record Q4 revenue, debt reduction, and committing $1b to expand its Miami hub. See our latest analysis for American Airlines Group. Despite record Q4 revenue, debt reduction and the Miami expansion plan, American Airlines Group’s recent share price returns have been weak, with a 30 day share price return showing a 5.86% decline and a 1 year...

Doximity, Inc. recently presented at the ViVE 2026 conference in Los Angeles, where co-founder and CEO Jeffrey A. Tangney outlined the company’s latest digital healthcare tools and platform capabilities for medical professionals. This appearance, alongside upbeat analyst commentary on Doximity’s role in telemedicine and clinician workflow, has sharpened investor focus on its position in digital healthcare. Next, we’ll explore how this heightened attention on Doximity’s telemedicine and...

If you are wondering whether TJX Companies is still good value at around US$159.94 per share, it helps to step back and look at what the recent share price and fundamentals are really telling you. The stock has returned 1.4% over the last 7 days, 6.8% over the past month, 3.7% year to date, 31.0% over 1 year and 112.9% and 164.0% over 3 and 5 years respectively, so many investors are asking whether the current price already reflects these outcomes. Recent coverage around TJX has focused on...

Home Depot stock performance and recent context Home Depot (HD) has been relatively steady recently, with the share price near $370.81 and mixed returns across different time frames, including a small decline over the past month and a gain over the past 3 months. For investors watching large U.S. retailers, the company’s current valuation metrics sit alongside trailing annual revenue of about $164.7b and net income of roughly $14.2b. This provides a sense of its scale in home improvement. See...

If you are wondering whether L3Harris Technologies at around US$378.48 is offering fair value right now, you are not alone; many investors are asking the same question. The stock has recorded returns of 6.6% over the last 7 days, 10.4% over 30 days, 24.3% year to date and 85.7% over 1 year, with 3 year and 5 year returns of 88.6% and 119.3% respectively, which naturally puts a spotlight on what you might be paying for each future dollar of cash flow. Recent coverage has focused on L3Harris...

Applied Industrial Technologies (AIT) is back in focus after director Peter C. Wallace sold 5,000 shares and the company released Q2 results highlighting solid sales, strong orders, and firm cash generation. See our latest analysis for Applied Industrial Technologies. AIT’s recent Q2 update and insider sale sit against a backdrop of steady price strength, with a 30 day share price return of 8.88% and a 1 year total shareholder return of 18.87%. This suggests momentum has been building rather...

If you are trying to figure out whether Healthpeak Properties is reasonably priced or offering a margin of safety, this article walks through what the current share price might be implying. The stock last closed at US$17.63, with returns of 1.9% over the past week, 2.3% over the past month, 8.8% year to date, and a 7.9% decline over the last year. This may leave you wondering whether the recent moves reflect changing risk or opportunity. Recent news flow around Healthpeak Properties has...